The Batia and Idan Ofer program for Validation of Interventions Targeting Aging and Longevity (BIO-VITAL) at Albert Einstein College of Medicine’s Institute for Geroscience (EIG) consists of three integrated research cores. From evaluating aging hallmarks at the cellular level to screening prospective compounds in preclinical models to validating results against human genetics, BIO-VITAL researchers partner with longevity biotech and pharmaceutical companies in their search for novel therapies that slow human aging.
Cellular Aging & Technology Core
The Cellular Aging and Technology Core (CATC) provides resources to conduct research on cellular drivers of aging, specifically autophagy, proteostasis, senescence, and mitochondria function. In addition to offering a range of assays, reagents, and samples, CATC provides consultation on experimental design, data analysis and interpretation, and can coordinate efforts across the institute’s other cores.
CATC assays and tools are:
- Optimized for drug discovery
- Use functional high-content microscopy platforms and ultrastructural mophrometric analysis
- Adaptable to multiple cell types, including human
- Include data mining and indexes
- Available to institute members, outside academic institutions, private institutions, industry, and foundations
Assays include:
- Functional fluorescent reporters & assessments
- Biomedical & image-based readouts
- Data mining
Core Director
Ana Maria Cuervo, M.D., Ph.D.
Preclinical Aging Models Core
The Preclinical Aging Models Core (PAMC) offers access to a propriety mouse model to evaluate human aging. An extensively validated approach allows PAMC to precisely monitor the animal model lifespan and measure the impact of an intervention, by measuring stamina, coordination, memory, and metabolism.
PAMC can create a custom preclinical workflow to measure:
- physical function, including grip strength, fine motor coordination, blood pressure monitoring, and frailty index.
- metabolic function, through body composition and endocrine profiling.
- cognitive and behavioral phenotyping, using mazes, AI-driven continuous monitoring home cages, and physical challenge assays.
Core Director
Derek Huffman, Ph.D.
Human Longevity Multi-omics Core
The Human Longevity Multi-omics Core (HLMC) draws on a deep reservoir of genetics and omics data from those with exception longevity, as well as those with no family history of longevity, to discover mechanism of aging and to develop novel therapeutics. We can assist companies to demonstrate proof-of-concept by evaluating compounds against genes and proteins known for their contribution to longevity.
Datasets include:
- whole exome sequencing (WES)
- SNP arrays
- DNA methylation arrays
- proteomics
Core Directors
Core Director
Nir Barzilai, M.D.
Core Co-Director
Sofiya Milman, M.D., M.S.